Cancer Peptides Plus GM-CSF and Adjuvant in Breast Cancer
Clinical trial NCT04270149 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04270149
- Sponsor
- Herbert Lyerly
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-01
- Primary completion
- 2025-05-30
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.